VTE prophylaxis

Ward jobs

Assess VTE and bleeding risk on admission, at consultant review, and whenever the patient's condition changes.

If VTE risk outweighs bleeding risk, start LMWH as soon as possible and within 14 hours of admission.

Act now

  1. 1

    Already on full-dose anticoagulation: no extra prophylaxis needed.

  2. 2

    Pharmacological prophylaxis contraindicated: offer mechanical prophylaxis (anti-embolism stockings or intermittent pneumatic compression) if appropriate.

Assess

  • VTE risk: reduced mobility, active cancer, age over 60, obesity, previous VTE, thrombophilia, oestrogen therapy, dehydration, critical care admission.
  • Bleeding risk: active bleeding, platelets under 75, already anticoagulated, acute stroke, uncontrolled hypertension, recent or planned spinal or epidural procedure.
  • Weight, creatinine clearance and platelet count.

Investigations

  • FBC and U&E before starting. Recheck platelets if heparin was given in the last 100 days (heparin-induced thrombocytopenia risk).

Manage

  • Medical patients: continue for at least 7 days, or until no longer at increased risk.
  • Acute stroke: use intermittent pneumatic compression, not anti-embolism stockings.
  • Avoid stockings with peripheral arterial disease, peripheral neuropathy, leg ulcers or fragile skin.
  • Spinal or epidural: check timing with anaesthetics (usually at least 12 hours after a prophylactic LMWH dose).

Escalate when

  • Bleeding on prophylaxis, platelets falling by more than half, or high VTE and bleeding risk together: senior or haematology.

Doses and prescribing

Enoxaparin

40 mg SC once daily. Creatinine clearance 15–30 mL/min: 20 mg once daily. Under 15 mL/min: discuss (unfractionated heparin is often used).

Very low or high body weight: adjust per local policy — use the enoxaparin calculator.

Alternatives: dalteparin 5000 units SC once daily; fondaparinux 2.5 mg SC once daily (reduce or avoid in renal impairment).

Check the BNF and your local formulary before prescribing.

Written to current guidance (NICE NG89) · sources checked 16 Nov 2026. We watch NICE for updates weekly.

Sources (2)

Reviewed by Aboodee Alhasso, MPharm MRCPharm IP on 16 Nov 2026

For healthcare professionals, as an aid to clinical judgement — not a substitute for it. Follow your local policy and ask a senior when in doubt.